Zotefoams plc (LON:ZTF) insider Gary McGrath purchased 32 shares of the firm’s stock in a transaction that occurred on Thursday, January 11th. The shares were acquired at an average cost of GBX 464 ($6.29) per share, for a total transaction of £148.48 ($201.36).
Gary McGrath also recently made the following trade(s):
- On Monday, December 11th, Gary McGrath acquired 37 shares of Zotefoams stock. The shares were purchased at an average price of GBX 408 ($5.53) per share, for a total transaction of £150.96 ($204.72).
- On Tuesday, November 14th, Gary McGrath acquired 39 shares of Zotefoams stock. The shares were purchased at an average price of GBX 384 ($5.21) per share, for a total transaction of £149.76 ($203.09).
Zotefoams plc (LON ZTF) opened at GBX 459 ($6.22) on Friday. Zotefoams plc has a 1 year low of GBX 264.45 ($3.59) and a 1 year high of GBX 475.52 ($6.45). The firm has a market cap of $203.64 and a price-to-earnings ratio of 3,530.77.
A number of research firms have weighed in on ZTF. N+1 Singer reiterated a “buy” rating on shares of Zotefoams in a research report on Friday, November 3rd. Peel Hunt boosted their price objective on shares of Zotefoams from GBX 325 ($4.41) to GBX 360 ($4.88) and gave the company an “add” rating in a research report on Tuesday, October 31st.
Zotefoams Company Profile
Zotefoams plc is a United Kingdom-based cellular material technology company. The Company is engaged in the manufacture and sale of cross-linked block foams. The Company’s segments include Polyolefins, High-Performance Products (HPP) and MuCell Extrusion LLC (MEL). Polyolefins foams are made from olefinic homopolymer and copolymer resin.
Receive News & Ratings for Zotefoams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zotefoams and related companies with MarketBeat.com's FREE daily email newsletter.